241 related articles for article (PubMed ID: 17019624)
21. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
Ghanizadeh A; Ayoobzadehshirazi A
Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
[TBL] [Abstract][Full Text] [Related]
22. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Asadabadi M; Mohammadi MR; Shahei M; Tabrizi M; Hajiaghaee R; Hassanzadeh E; Akhondzadeh S
Int J Neuropsychopharmacol; 2013 May; 16(4):783-9. PubMed ID: 22999292
[TBL] [Abstract][Full Text] [Related]
23. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
Van Bellinghen M; De Troch C
J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
[TBL] [Abstract][Full Text] [Related]
24. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
Research Units on Pediatric Psychopharmacology Autism Network
Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
[TBL] [Abstract][Full Text] [Related]
25. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
26. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
[TBL] [Abstract][Full Text] [Related]
29. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
[TBL] [Abstract][Full Text] [Related]
30. Risperidone in children with autism: randomized, placebo-controlled, double-blind study.
Nagaraj R; Singhi P; Malhi P
J Child Neurol; 2006 Jun; 21(6):450-5. PubMed ID: 16948927
[TBL] [Abstract][Full Text] [Related]
31. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial.
Khalaj M; Saghazadeh A; Shirazi E; Shalbafan MR; Alavi K; Shooshtari MH; Laksari FY; Hosseini M; Mohammadi MR; Akhondzadeh S
J Psychiatr Res; 2018 Aug; 103():104-111. PubMed ID: 29807317
[TBL] [Abstract][Full Text] [Related]
32. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
Luby J; Mrakotsky C; Stalets MM; Belden A; Heffelfinger A; Williams M; Spitznagel E
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):575-87. PubMed ID: 17069546
[TBL] [Abstract][Full Text] [Related]
33. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
34. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
[TBL] [Abstract][Full Text] [Related]
36. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
37. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study.
Biederman J; Mick E; Faraone SV; Wozniak J; Spencer T; Pandina G
Clin Ther; 2006 May; 28(5):794-800. PubMed ID: 16861101
[TBL] [Abstract][Full Text] [Related]
38. Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial.
Miral S; Gencer O; Inal-Emiroglu FN; Baykara B; Baykara A; Dirik E
Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):1-8. PubMed ID: 18080171
[TBL] [Abstract][Full Text] [Related]
39. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
[TBL] [Abstract][Full Text] [Related]
40. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
Ghanizadeh A; Sahraeizadeh A; Berk M
Child Psychiatry Hum Dev; 2014; 45(2):185-92. PubMed ID: 23801256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]